Telomir Pharmaceuticals, Inc | WebDisclosure

Basculer en Français

10161	Companies
208730	Keywords
138855	Articles
110646	Press releases

Headlines Articles Press releases Telomir Pharmaceuticals, Inc

Home
Companies
Telomir Pharmaceuticals, Inc

PRESS RELEASE

published on 01/07/2025 at 14:00, 1 year 2 months ago

Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
Telomir Pharmaceuticals announces potentially groundbreaking findings from preclinical progeria lifespan study demonstrating restoration of shortened lifespan and normalization of accelerated aging with Telomir-1

Telomir-1 Telomir Pharmaceuticals Progeria Study Lifespan Restoration Accelerated Aging
BRIEF

published on 12/23/2024 at 13:35, 1 year 3 months ago

Telomir Pharmaceuticals Unveils Copper Binding Breakthrough in Telomir-1

Therapeutic Potential Telomir-1 Wilson's Disease Copper Binding Anti-aging Market
BRIEF

published on 12/23/2024 at 13:35, 1 year 3 months ago

Telomir Pharmaceuticals dévoile une percée dans la liaison du cuivre dans Telomir-1

Telomir-1 Maladie De Wilson Reliure En Cuivre Potentiel Thérapeutique Marché Anti-âge
PRESS RELEASE

published on 12/23/2024 at 13:30, 1 year 3 months ago

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease
Telomir Pharmaceuticals announces promising findings from copper binding studies with Telomir-1, addressing Wilson's disease and metal toxicity. Telomir-1 shows potential in preclinical models for multiple conditions

Telomir-1 Telomir Pharmaceuticals Wilson's Disease Copper Binding Metal Toxicity
BRIEF

published on 12/12/2024 at 14:35, 1 year 3 months ago

Telomir Pharmaceuticals Secures $1 Million Equity Funding at Premium

Financial Strategy Preclinical Results Telomir-1 Age-Reversal Equity Funding
BRIEF

published on 12/12/2024 at 14:35, 1 year 3 months ago

Telomir Pharmaceuticals obtient un financement par actions de 1 million de dollars à prime

Stratégie Financière Financement Par Actions Résultats Précliniques Telomir-1 Inversion Du Vieillissement
PRESS RELEASE

published on 12/12/2024 at 14:30, 1 year 3 months ago

Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price
Telomir Pharmaceuticals, Inc. raises $1 million in equity funding through The Starwood Trust, reinforcing financial strength. Telomir-1 shows transformative potential in addressing age-related conditions

Financial Strength Telomir-1 Telomir Pharmaceuticals Age-reversal Science Equity Funding
BRIEF

published on 12/03/2024 at 13:35, 1 year 4 months ago

Telomir Pharmaceuticals Reveals Promising Preclinical Diabetes Study

Preclinical Study Type 2 Diabetes Telomir-1 Telomir Pharmaceuticals Insulin Resistance
BRIEF

published on 12/03/2024 at 13:35, 1 year 4 months ago

Telomir Pharmaceuticals révèle une étude préclinique prometteuse sur le diabète

Étude Préclinique Diabète De Type 2 Telomir-1 Telomir Pharmaceuticals Résistance À L'insuline
PRESS RELEASE

published on 12/03/2024 at 13:30, 1 year 4 months ago

Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1
Telomir Pharmaceuticals announces groundbreaking preclinical results showcasing Telomir-1's efficacy in reversing key parameters of Type 2 diabetes mellitus, potentially addressing insulin resistance at its root

Preclinical Results Type 2 Diabetes Telomir-1 Telomir Pharmaceuticals Insulin Resistance

Accesswire

Published on 04/02/2026 at 22:00, 1 day 4 hours ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 1 day 7 hours ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 1 day 11 hours ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 1 day 11 hours ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 1 day 11 hours ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/04/2026 at 02:05, 5 minutes ago

Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 8 hours 10 minutes ago

IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 8 hours 10 minutes ago

IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 8 hours 25 minutes ago

Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 17:40, 8 hours 30 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.04.26.

Les Echos

Published on 04/03/2026 at 18:46, 7 hours 23 minutes ago

Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 7 hours 23 minutes ago

Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 8 hours 8 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 8 hours 10 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 8 hours 10 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026

View all LES ECHOS COMFI WIRE